Erratum: Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma (Journal of Clinical Investigation (2019) 129:8 (3464) DOI:10.1172/JCI131246)

Meenakshi Hegde, Malini Mukherjee, Zakaria Grada, Antonella Pignata, Daniel Landi, Shoba A. Navai, Amanda Wakefield, Kristen Fousek, Kevin Bielamowicz, Kevin K.H. Chow, Vita S. Brawley, Tiara T. Byrd, Simone Krebs, Stephen Gottschalk, Winfried S. Wels, Matthew L. Baker, Gianpietro Dotti, Maksim Mamonkin, Malcolm K. Brenner, Jordan S. OrangeNabil Ahmed

Research output: Contribution to journalComment/debate

3 Scopus citations

Abstract

A reader recently alerted the Journal that two images in this JCI article appear similar to images subsequently published in a Neuro-Oncology paper from the same lab as unique samples (1). Specifically, in Figure 9D of the JCI paper, the image for IL13Rα2 staining for the HER2 CAR sample appears to be similar to the image for EphA2 staining of a nontransduced T cell–treated sample published in Figure 6A of the Neuro-Oncology paper. In addition, in Figure 9D of the JCI paper, the image for IL13Rα2 staining for the tumor sample appears to be similar to the image for HER2 staining of a nontransduced T cell–treated sample in Figure 6B of the Neuro-Oncology paper. An institutional investigation into this matter is ongoing, and we will inform our readers of the outcome when the investigation is complete.

Original languageEnglish (US)
Number of pages1
JournalJournal of Clinical Investigation
Volume129
Issue number8
DOIs
StatePublished - Aug 1 2019

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Erratum: Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma (Journal of Clinical Investigation (2019) 129:8 (3464) DOI:10.1172/JCI131246)'. Together they form a unique fingerprint.

Cite this